New and better information for scientists, toward novel therapeutic strategies in cancer and congenital disorders. We design, we produce and we provide research tools for gene expression analysis at the ribosomal level
We are engaged with customers at every step of the way.
The team leading IMMAGINA is composed by an experienced group of scientists, and c-level professionals,
offering a mix of competencies that range from molecular biology, chemistry, nanotechnology, technology transfer,
marketing and business development. Among them, members of TBA (http://t-ba.eu/), BAN-TN (http://www.iban.it/it/mappa-dei-ban) and I.E.C.T. (the Hermann Hauser - Institute for Entrepreneurship, http://www.iect.at/homepage/). The achievement of the many ambitious goals is sustained by the already accomplished R&D activities funded by both private and public stakeholders. Further, IMMAGINA relies on a series of partnerships already established to help the business and market development.
We deliver high-quality solutions to assess translational control of gene expression and translatome-associated biomarkers.
The Ribosome Company
IMMAGINA designed, developed and commercialize a Specialized Ribosome Technology Platform to isolate and analyse active ribosomes and the associated RNA molecules that are being translated into proteins. The present platform includes several products and the following technologies: RP_RiboLace, RiboMINATI, RiboNext, Smart Beads and dedicated library-prep kits for Illumina and Oxford Nanopore sequencing instruments.
IMMAGINA ambition is to deliver smart solutions for truer gene expression analysis in research and hospital labs, to support life science worldwide. We are working to provide you with the best picture of gene expression. Because the message is only part of the story.
Wants to join the startup company to help accomplish our mission?
Please send Curriculum vitae, a letter describing your interest and contact details of three references to email@example.com. We will contact you if a new position will be open.
Scientific publication – ACS Omega – 06/2019
Targeting Translation Activity at the Ribosome Interface with UV-Active Small Molecules UV-active puromycin derivatives that cannot be transferred to the growing peptide chain can be used to study protein synthesis activity and label productive ribosome-associated protein (http://doi.org/10.1021/acsomega.9b00366). Compounds available in the store online
New patent / Novel agarose-based graphene beads and uses thereof – 09/2017
We announce a new patent describing new tools for specific catalytic reactions, adsorption and separation of molecules. New achievements in chemistry, biotechnology and environmental fields are now possible!
Our first paper reporting the basic of our RiboLace technology Active ribosome profiling with RiboLace is now public available on bioRxiv. The paper describes a novel method based on an original puromycin-containing molecule capable of isolating active ribosomes by means of an antibody-free and tag-free pull-down approach. RiboLace is fast, works reliably with low amounts of input material, […]